Is Most-Watched Stock Novo Nordisk A/S (NVO) Worth Betting on Now?

What happened: Novo Nordisk (NVO) is among the most watched stocks on Zacks.com, and the article reviews factors that may affect its near-term performance. Key numbers: Shares returned -19.4% over the past month versus +0.8% for the Zacks S&P 500 composite. The Zacks Large Cap Pharmaceuticals industry lost 4.9%. Why it matters: Zacks says earnings estimate revisions correlate with short-term price moves, and the recent consensus change plus three other earnings-related factors give Novo Nordisk a Zacks Rank #3 (Hold).

Novo Nordisk (NVO) is among the most watched stocks on Zacks.com, and the article reviews factors that may affect its near-term performance.

Zacks says earnings estimate revisions correlate with short-term price moves, and the recent consensus change plus three other earnings-related factors give Novo Nordisk a Zacks Rank #3 (Hold).